Literature DB >> 29498581

Primary spinal cord astroblastoma: case report.

Shoko Merrit Yamada1, Yusuke Tomita1, Soichiro Shibui1, Mikiko Takahashi2, Masashi Kawamoto2, Sumihito Nobusawa3, Junko Hirato4.   

Abstract

Astroblastoma is a rare tumor that is thought to occur exclusively in the cerebrum. To the authors' knowledge, no cases of spinal cord astroblastoma have been reported. A 20-year-old woman presented with numbness in her legs. MRI demonstrated a 2-cm intramedullary enhancing lesion in the spinal cord at the T-1 level. The patient declined to undergo resection of the tumor because she was able to walk unassisted; however, she returned for surgery 1 month later because she had developed paraplegia with bladder and rectal dysfunction, and MRI showed enlargement of the tumor. Intraoperatively, the border between the tumor and normal tissue was poorly defined. Biopsy samples were obtained for histopathological examinations, and a diagnosis of astroblastoma with a Ki-67 index of 5% was made. Considering the rapid tumor growth on MRI and remarkable deterioration in her symptoms, the patient was treated with a combination of radiation therapy, temozolomide (TMZ), and bevacizumab. After completion of the combined treatment, she was able to move her toes, and oral TMZ and bevacizumab injections were continued. Six months later, definite tumor shrinkage was identified on MRI, and the patient was able to stand up from a wheelchair without assistance and walk by herself. No therapeutic regimens for residual astroblastoma are established; however, in this case the authors' therapeutic strategy was successful in treating the spinal cord astroblastoma.

Entities:  

Keywords:  EMA = epithelial membrane antigen; FISH = fluorescence in situ hybridization; TMZ = temozolomide; astroblastoma; bevacizumab; oncology; radiation; spinal cord; temozolomide

Mesh:

Year:  2018        PMID: 29498581     DOI: 10.3171/2017.9.SPINE161302

Source DB:  PubMed          Journal:  J Neurosurg Spine        ISSN: 1547-5646


  3 in total

1.  Recurrent HGNET-MN1 altered (astroblastoma MN1-altered) of the foramen magnum: Case report and molecular classification.

Authors:  Sricharan Gopakumar; Malcolm F McDonald; Himanshu Sharma; Claudio E Tatsui; Gregory N Fuller; Ganesh Rao
Journal:  Surg Neurol Int       Date:  2022-04-15

2.  Cerebral astroblastoma radiologically mimicking pilocytic astrocytoma: A case report.

Authors:  Padam Raj Joshi; Sagar Babu Pandey; Usha Manandhar; Saroj Gc; Gopal Sedain
Journal:  Clin Case Rep       Date:  2022-04-25

3.  Spinal cord astroblastoma with EWSR1-BEND2 fusion classified as HGNET-MN1 by methylation classification: a case report.

Authors:  Takeyoshi Tsutsui; Yoshiki Arakawa; Yasuhide Makino; Hiroharu Kataoka; Yohei Mineharu; Kentaro Naito; Sachiko Minamiguchi; Takanori Hirose; Sumihito Nobusawa; Yoshiko Nakano; Koichi Ichimura; Hironori Haga; Susumu Miyamoto
Journal:  Brain Tumor Pathol       Date:  2021-07-27       Impact factor: 3.298

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.